Share Twitter LinkedIn Facebook Email Jeanny B. Aragon-Ching, MD, FACP, discusses how new guidelines have changed the treatment of advanced metastatic bladder cancer. Advertisement
FDA Approves INLEXZO™ / Gemcitabine Intravesical: A Breakthrough for Bladder Cancer Treatment Bladder 4 Mins Read
FDA Approves New Bladder Cancer Therapy: A Look at Anktiva Nogapendekin Alfa Inbakicept-pmln Bladder 4 Mins Read
